id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S17739 R74980 |
Zhu - Fluconazole, 2020 | Any congenital malformation | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Fluconazole not specified or mixed dose | 1.02 [0.97;1.07] | 1,457/37,648 71,274/1,872,961 | 72,731 | 37,648 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17833 R75267 |
Berard - Fluconazole, 2019 | Major congenital malformation (according ICD-9 and 10) | 1st trimester | nested case control | unexposed (general population or NOS) | Adjustment: Yes Fluconazole not specified or mixed dose | 1.18 [0.95;1.48] | 142/1,313 19,346/225,286 | 19,488 | 1,313 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17734 R74915 |
Howley - Fluconazole, 2016 | At least one or more of 30 different categories of major structural birth defects | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No Fluconazole not specified or mixed dose | 2.69 [1.15;6.32] C | 44/50 31,601/43,207 | 31,645 | 50 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17735 R74931 |
Molgaard-Nielsen - Fluconazole, 2013 | Major birth defects | 1st trimester | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes Fluconazole not specified or mixed dose | 1.06 [0.92;1.21] | 210/7,352 25,159/968,236 | 25,369 | 7,352 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17748 R75072 |
De Santis - Itraconazole, 2009 | Major congenital anomalies | 1st trimester | prospective cohort | unexposed (general population or NOS) | Adjustment: No Matched | 0.87 [0.19;3.95] C | 3/163 4/190 | 7 | 163 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17728 R74813 |
Kazy - Ketoconazole, 2005 | Congenital abnormality | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes | 1.40 [0.40;4.80] | 5/11 22,838/60,983 | 22,843 | 11 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17747 R75062 |
Bar-Oz - Itraconazole, 2000 | Major birth defects | 1st trimester | prospective cohort | unexposed (general population or NOS) | Adjustment: No Matched | 0.67 [0.23;1.95] | 5/156 9/187 | 14 | 156 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17745 R75037 |
Jick - Fluconazole and Itraconazole (Oral), 1999 | Congenital anomaly | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No | 1.37 [0.59;3.18] C | 7/322 26/1,629 | 33 | 322 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17737 R74935 |
Sorensen - Fluconazole, 1999 | Malformations (ICD8 were 740.00–759.99 and Q0.00-Q99.9 in the ICD10) | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Fluconazole not specified or mixed dose | 0.65 [0.24;1.77] | 4/121 697/13,327 | 701 | 121 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17733 R74848 |
Mastroiacovo - Fluconazole, 1996 | Congenital anomalies that warranted medical or surgical treatment | 1st trimester | prospective cohort | unexposed (general population or NOS) | Adjustment: Yes Fluconazole not specified or mixed dose Matched | 1.07 [0.41;2.77] | 7/177 17/409 | 24 | 177 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17731 R74830 |
Inman - Fluconazole, 1994 | Abnormalities in foetuses | during pregnancy (anytime or not specified) excluded | retrospective cohort | unexposed, sick | Adjustment: No Fluconazole not specified or mixed dose |
0.27 [0.01;4.92] C excluded (exposition period) |
0/43 5/130 | 5 | 43 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S17724 R74790 |
Rosa - Miconazole, 1987 | Birth defects | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No | 1.02 [0.90;1.20] | 144/2,236 6,420/102,103 | 6,564 | 2,236 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 11 studies | 1.03 [0.99;1.08] | 179,419 | 49,549 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Oral;
Asymetry test p-value = 0.3488 (by Egger's regression)
slope=0.0161 (0.0256); intercept=0.3482 (0.3523); t=0.9884; p=0.3488
excluded